Shire Share News (SHP)

STOCKS NEWS EUROPE-Shire strong riser on patent trial win

Shares in drugs group Shire are the second-top risers on Britain's FTSE 100 index in brisk trade after the company on Thursday says it has won a paten
[10 May '13]

ADR REPORT-ECB rate cut, jobless claims data lift ADRs

By Chuck MikolajczakNEW YORK, May 2 (Reuters) - U.S.-listed shares of foreign companies rose on Thursday, buoyed by an interest rate cut from the Euro
[2 May '13]

UPDATE 2-Shire cuts sales forecast as drugs miss Q1 targets

* Reduces full-year product forecast to high single-digits* Q1 beats on earnings, although revenue misses* New CEO reorganizes company to drive revenu
[2 May '13]

Shire delivers Q1 earnings beat on strong product sales

LONDON, May 2 (Reuters) - British pharmaceutical firm Shire beat expectations with a 10 percent rise in first-quarter earnings on Thursday after a st
[2 May '13]

Actavis settles OxyContin lawsuit with Purdue

April 26 (Reuters) - Generic drugmaker Actavis Inc said it had settled a patent lawsuit with Purdue Pharma related to Actavis' generic version of the
[26 Apr '13]

Shire settles with Actavis, Watson Pharma on ADHD drug

April 25 (Reuters) - Drugmaker Shire Plc said it settled all litigation with Actavis Inc and Watson Pharma, allowing the two companies to sell a gener
[25 Apr '13]

UPDATE 2-AstraZeneca buys early-stage U.S. biotech firm

* MedImmune unit acquires private company AlphaCore Pharma* Deal shows focus of new AstraZeneca CEO on novel science* AlphaCore developing new approac
[3 Apr '13]

Third Rock Ventures raises $516 million fund

SAN FRANCISCO, March 25 (Reuters) - Healthcare-oriented venture firm Third Rock Ventures said it had raised a $516 million fund, its third, even as he
[26 Mar '13]